Pure Peptides Full Width Reconstitution Guide v8
Pure Peptides PH · simple clinician reference

Easy-Dose Peptide Reconstitution Guide

A simple product-by-product reference for reconstitution, concentration, and U-100 syringe draw volumes. Open any product to view the suggested mix amount, common dose table, and practical notes.

U-100 syringe basics100 U = 1 mL. 10 U = 0.10 mL. 5 U = 0.05 mL.
Concentration formulaVial mg ÷ water mL = mg/mL. Example: 10 mg + 2 mL = 5 mg/mL.
Example draw mathAt 5 mg/mL, 100 U contains 5 mg, 20 U contains 1 mg, and 10 U contains 0.5 mg.
Mixing basicsAdd slowly down the glass wall, swirl gently, label the vial, then refrigerate after mixing.

Dose calculator

Use this for any vial. The amount of water added is adjustable; it changes the concentration and how many units to draw, but the total peptide in the vial stays the same.

Label / approved moleculeHuman trialCommon off-labelDiluent

1) Mix

Add 2 mL BAC water. This makes 2.5 mg/mL. On U-100: 10 U = 0.25 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Often positioned as a fat-metabolism peptide; human evidence is more limited than GLP-1 drugs.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 0.25 mg Daily 10 U 20 doses/vial
Common 0.5 mg Daily 20 U 10 doses/vial
Higher 1 mg Daily; clinician-only 40 U 5 doses/vial

Note: 5 mg + 2 mL = 2.5 mg/mL; 0.25 mg = 10 U and 0.5 mg = 20 U.

Pure Peptides catalog lists AOD-9604 5 mg

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Amylin-pathway compound studied for satiety and appetite control, often discussed with GLP-1 stacks.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Simple low 0.5 mg 1× weekly × 4 weeks 10 U 20 doses/vial
Simple step 1 mg 1× weekly × 4 weeks 20 U 10 doses/vial
Simple step 2 mg 1× weekly × 4 weeks 40 U 5 doses/vial
Near trial 2.4 mgrounded easy draw 2.5 mg 1× weekly × 4 weeks 50 U 4 doses/vial
Trial high 4.5 mg 1× weekly × 4 weeks 90 U 2.2 doses/vial

Note: Phase 2 trial arms were 0.3, 0.6, 1.2, 2.4, and 4.5 mg weekly. This table uses 5 mg/mL for simpler 10U/20U/40U/50U draws.

Pure Peptides product page: Cagrilintide 10 mgPubMed cagrilintide Phase 2 trial arms

1) Mix

Add 1 mL BAC water. This makes 10 mg/mL. On U-100: 10 U = 1 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Investigational triple agonist that targets appetite, metabolic rate signaling, and glucose/weight pathways.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low start 1 mg 1× weekly × 4 weeks 10 U 10 doses/vial
Trial start 2 mg 1× weekly × 4 weeks 20 U 5 doses/vial
Trial arm 4 mg 1× weekly × 4 weeks 40 U 2.5 doses/vial
Mid step 6 mg 1× weekly × 4 weeks 60 U 1.7 doses/vial
Trial arm 8 mg 1× weekly × 4 weeks 80 U 1.2 doses/vial
Max from this vial 10 mg 1× weekly × 4 weeks; full vial 100 U 1 doses/vial

Note: 10 mg vial uses 10 mg as the practical max. Published Phase 2 arms included once-weekly 1, 4, 8, and 12 mg groups with escalation variants.

Pure Peptides catalog/homepage lists Retatrutide 10/30/60 mgPubMed retatrutide Phase 2 dosing arms

1) Mix

Add 1.5 mL BAC water. This makes 20 mg/mL. On U-100: 10 U = 2 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Investigational triple agonist that targets appetite, metabolic rate signaling, and glucose/weight pathways.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low start 1 mg 1× weekly × 4 weeks 5 U 30 doses/vial
Trial start 2 mg 1× weekly × 4 weeks 10 U 15 doses/vial
Trial arm 4 mg 1× weekly × 4 weeks 20 U 7.5 doses/vial
Mid step 6 mg 1× weekly × 4 weeks 30 U 5 doses/vial
Trial arm 8 mg 1× weekly × 4 weeks 40 U 3.8 doses/vial
High trial arm 12 mg 1× weekly × 4 weeks 60 U 2.5 doses/vial

Note: 10 mg vial uses 10 mg as the practical max. Published Phase 2 arms included once-weekly 1, 4, 8, and 12 mg groups with escalation variants.

Pure Peptides catalog/homepage lists Retatrutide 10/30/60 mgPubMed retatrutide Phase 2 dosing arms

1) Mix

Add 3 mL BAC water. This makes 20 mg/mL. On U-100: 10 U = 2 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Investigational triple agonist that targets appetite, metabolic rate signaling, and glucose/weight pathways.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low start 1 mg 1× weekly × 4 weeks 5 U 60 doses/vial
Trial start 2 mg 1× weekly × 4 weeks 10 U 30 doses/vial
Trial arm 4 mg 1× weekly × 4 weeks 20 U 15 doses/vial
Mid step 6 mg 1× weekly × 4 weeks 30 U 10 doses/vial
Trial arm 8 mg 1× weekly × 4 weeks 40 U 7.5 doses/vial
High trial arm 12 mg 1× weekly × 4 weeks 60 U 5 doses/vial

Note: 10 mg vial uses 10 mg as the practical max. Published Phase 2 arms included once-weekly 1, 4, 8, and 12 mg groups with escalation variants.

Pure Peptides catalog/homepage lists Retatrutide 10/30/60 mgPubMed retatrutide Phase 2 dosing arms

1) Mix

Add 3 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Reduces appetite and slows gastric emptying through GLP-1 receptor activity.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Start 0.25 mg 1× weekly × 4 weeks 5 U 60 doses/vial
Step 1 0.5 mg 1× weekly × 4 weeks 10 U 30 doses/vial
Step 2 1 mg 1× weekly × 4 weeks 20 U 15 doses/vial
Near 1.7 mg steprounded easy draw 1.75 mg 1× weekly × 4 weeks 35 U 8.6 doses/vial
Near 2.4 mg targetrounded easy draw 2.5 mg 1× weekly × 4 weeks 50 U 6 doses/vial

Note: At 5 mg/mL, 0.25 mg = 5 U and 0.5 mg = 10 U. Exact 1.7 mg and 2.4 mg are 34 U and 48 U; table uses simple rounded draws.

Pure Peptides homepage references SemaglutideSemaglutide label dosing reference

1) Mix

Add 0.6 mL BAC water. This makes 25 mg/mL. On U-100: 10 U = 2.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Helps reduce appetite and improve metabolic control through GLP-1 and GIP receptor activity.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Start 2.5 mg 1× weekly × 4 weeks 10 U 6 doses/vial
Step 1 5 mg 1× weekly × 4 weeks 20 U 3 doses/vial
Step 2 7.5 mg 1× weekly × 4 weeks 30 U 2 doses/vial
Maintenance 10 mg 1× weekly × 4 weeks 40 U 1.5 doses/vial
Maintenance 12.5 mg 1× weekly × 4 weeks 50 U 1.2 doses/vial
Max label 15 mg 1× weekly × 4 weeks 60 U 1 doses/vial

Note: Easy GLP mix: 25 mg/mL, so 2.5 mg = 10 U. Escalate only when clinically appropriate.

Pure Peptides catalog lists Tirzepatide 15/30/60 mgFDA tirzepatide label dosing

1) Mix

Add 1.2 mL BAC water. This makes 25 mg/mL. On U-100: 10 U = 2.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Helps reduce appetite and improve metabolic control through GLP-1 and GIP receptor activity.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Start 2.5 mg 1× weekly × 4 weeks 10 U 12 doses/vial
Step 1 5 mg 1× weekly × 4 weeks 20 U 6 doses/vial
Step 2 7.5 mg 1× weekly × 4 weeks 30 U 4 doses/vial
Maintenance 10 mg 1× weekly × 4 weeks 40 U 3 doses/vial
Maintenance 12.5 mg 1× weekly × 4 weeks 50 U 2.4 doses/vial
Max label 15 mg 1× weekly × 4 weeks 60 U 2 doses/vial

Note: Easy GLP mix: 25 mg/mL, so 2.5 mg = 10 U. Escalate only when clinically appropriate.

Pure Peptides catalog lists Tirzepatide 15/30/60 mgFDA tirzepatide label dosing

1) Mix

Add 2.4 mL BAC water. This makes 25 mg/mL. On U-100: 10 U = 2.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Helps reduce appetite and improve metabolic control through GLP-1 and GIP receptor activity.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Start 2.5 mg 1× weekly × 4 weeks 10 U 24 doses/vial
Step 1 5 mg 1× weekly × 4 weeks 20 U 12 doses/vial
Step 2 7.5 mg 1× weekly × 4 weeks 30 U 8 doses/vial
Maintenance 10 mg 1× weekly × 4 weeks 40 U 6 doses/vial
Maintenance 12.5 mg 1× weekly × 4 weeks 50 U 4.8 doses/vial
Max label 15 mg 1× weekly × 4 weeks 60 U 4 doses/vial

Note: Easy GLP mix: 25 mg/mL, so 2.5 mg = 10 U. Escalate only when clinically appropriate.

Pure Peptides catalog lists Tirzepatide 15/30/60 mgFDA tirzepatide label dosing

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

CJC No DAC supports GHRH signaling; Ipamorelin is a selective GH secretagogue. Commonly paired before bed.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Common 0.25 mg + 0.25 mg Nightly or 5× weekly 10 U 40 doses/vial
Higher 0.375 mg + 0.375 mg Nightly; clinician-only 15 U 26 doses/vial
Upper common 0.5 mg + 0.5 mg Nightly; clinician-only 20 U 20 doses/vial

Note: Assumes 10 mg total = 5 mg CJC + 5 mg Ipamorelin. With 2 mL, 10 U gives about 0.25 mg of each component.

Pure Peptides product page says CJC1295 No DAC + Ipamorelin 10 mg and includes 3 mL BAC kit

1) Mix

Add 2.4 mL BAC water. This makes 10 IU/mL. On U-100: 10 U = 1 IU.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Exogenous growth hormone used clinically for GH deficiency; wellness/aesthetic protocols are off-label and need monitoring.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Adult GHD start 0.5 IU Daily; titrate 5 U 48 doses/vial
Common low 1 IU Daily or 5× weekly 10 U 24 doses/vial
Common wellness 2 IU Daily or 5× weekly 20 U 12 doses/vial
High supervised 4 IU Daily; clinician-only 40 U 6 doses/vial

Note: 1 mg somatropin ≈ 3 IU. This mix is 10 IU/mL, so 1 IU = 10 U.

Somatropin adult GHD starting dose label

1) Mix

Add 2 mL BAC water. This makes 10 mg/mL. On U-100: 10 U = 1 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Stimulates endogenous GH pulse through GHRH signaling; clinically used for excess visceral abdominal fat in HIV lipodystrophy.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 1 mg Daily 10 U 20 doses/vial
Common 1.5 mg Daily 15 U 13.3 doses/vial
Older/common ref 2 mg Daily 20 U 10 doses/vial

Note: 20 mg + 2 mL = 10 mg/mL, so the draw is very simple: 1 mg = 10 U and 2 mg = 20 U. Exact EGRIFTA WR dose is 1.28 mg daily; use clinician judgment when converting to this concentration.

Pure Peptides catalogFDA EGRIFTA WR label

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Stimulates endogenous GH pulse through GHRH signaling; clinically used for excess visceral abdominal fat in HIV lipodystrophy.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Rounded WR dosenear 1.28 mg 1.25 mg Daily 25 U 8 doses/vial
Older/common ref 2 mg Daily 40 U 5 doses/vial

Note: Exact EGRIFTA WR dose is 1.28 mg daily; this table uses 1.25 mg = 25 U at 5 mg/mL for an easy near-equivalent draw.

Pure Peptides catalog lists Tesamorelin 5/10 mgFDA EGRIFTA WR label

1) Mix

Add 1 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Stimulates endogenous GH pulse through GHRH signaling; clinically used for excess visceral abdominal fat in HIV lipodystrophy.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Rounded WR dosenear 1.28 mg 1.25 mg Daily 25 U 4 doses/vial
Older/common ref 2 mg Daily 40 U 2.5 doses/vial

Note: Exact EGRIFTA WR dose is 1.28 mg daily; this table uses 1.25 mg = 25 U at 5 mg/mL for an easy near-equivalent draw.

Pure Peptides catalog lists Tesamorelin 5/10 mgFDA EGRIFTA WR label

1) Mix

Add 2 mL BAC water. This makes 5000 IU/mL. On U-100: 10 U = 500 IU.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Acts like LH at the testis, supporting intratesticular testosterone and spermatogenesis in appropriate clinical contexts.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low support 250 IU 2–3× weekly × 4 weeks 5 U 40 doses/vial
Common support 500 IU 2–3× weekly × 4 weeks 10 U 20 doses/vial
Label low 1000 IU 2–3× weekly × 4 weeks 20 U 10 doses/vial
Fertility range 1500 IU 2–3× weekly × 4 weeks 30 U 6.7 doses/vial
Fertility range 2000 IU 2–3× weekly × 4 weeks 40 U 5 doses/vial
High label 4000 IU 3× weekly × 4 weeks; specialist-only 80 U 2.5 doses/vial

Note: 10,000 IU + 2 mL = 5,000 IU/mL. Very simple: 500 IU = 10 U, 1,000 IU = 20 U.

Pure Peptides homepage featured product HCG 10,000 IUPregnyl hCG label dosing

1) Mix

Add 1 mL BAC water. This makes 10 mg/mL. On U-100: 10 U = 1 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Studied mostly preclinically, with limited human analog data. Common clinics use weekly cycles.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 5 mg 1× weekly × 4 weeks 50 U 2 doses/vial
Split weekly 5 mg 2× weekly × 4 weeks = 10 mg/week 50 U 2 doses/vial
Higher 10 mg 1× weekly × 4 weeks or split; clinician-only 100 U 1 doses/vial

Note: Common online-clinic range: 5–10 mg/week, often 8–12 weeks on then 4 weeks off.

Pure Peptides catalog/homepage lists MOTS-c 10 mg and 40 mgMOTS-c evidence review

1) Mix

Add 2 mL BAC water. This makes 20 mg/mL. On U-100: 10 U = 2 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Studied mostly preclinically, with limited human analog data. Common clinics use weekly cycles.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 5 mg 1× weekly × 4 weeks 25 U 8 doses/vial
Split weekly 5 mg 2× weekly × 4 weeks = 10 mg/week 25 U 8 doses/vial
Higher 10 mg 1× weekly × 4 weeks or split; clinician-only 50 U 4 doses/vial

Note: Common online-clinic range: 5–10 mg/week, often 8–12 weeks on then 4 weeks off.

Pure Peptides catalog/homepage lists MOTS-c 10 mg and 40 mgMOTS-c evidence review

1) Mix

Add 2 mL BAC water. This makes 250 mg/mL. On U-100: 10 U = 25 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

NAD+ supports redox reactions and mitochondrial energy pathways; injection protocols vary widely.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low injection 25 mg 1–3× weekly × 4 weeks 10 U 20 doses/vial
Common injection 50 mg 1–3× weekly × 4 weeks 20 U 10 doses/vial
Higher injection 100 mg 1–2× weekly × 4 weeks 40 U 5 doses/vial

Note: 500 mg + 2 mL = 250 mg/mL. IV NAD+ protocols are different and should not be copied into SubQ dosing.

Pure Peptides catalog lists NAD+ 500 mg

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Binds cardiolipin/mitochondrial membranes in research literature; studied in mitochondrial disorders.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low common 1 mg Daily or 5× weekly 20 U 10 doses/vial
Common 2 mg Daily or 5× weekly 40 U 5 doses/vial
Higher common 5 mg Daily; clinician-only 100 U 2 doses/vial

Note: Approved elamipretide contexts use different commercial formulations; 40 mg/day trial/approved-style dosing would require multiple 10 mg vials.

Pure Peptides catalog lists SS-31 10 mgFDA elamipretide approval context

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Popular recovery peptide in sports/wellness clinics; human dosing evidence remains limited.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 0.25 mg Daily 5 U 40 doses/vial
Common 0.5 mg Daily 10 U 20 doses/vial
Split option 0.25 mg 2× daily = 0.5 mg/day 5 U 40 doses/vial
High short course 1 mg Daily; clinician-only 20 U 10 doses/vial

Note: Classic easy mix: 10 mg + 2 mL = 5 mg/mL. 0.25 mg = 5 U, 0.5 mg = 10 U.

Pure Peptides catalog lists BPC-157 10 mg

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

KPV has preclinical literature around intestinal inflammation and barrier signaling.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 0.25 mg Daily 5 U 40 doses/vial
Common 0.5 mg Daily 10 U 20 doses/vial
Higher 1 mg Daily; clinician-only 20 U 10 doses/vial

Note: 10 mg + 2 mL = 5 mg/mL. Same easy math as BPC: 0.25 mg = 5 U, 0.5 mg = 10 U.

KPV intestinal anti-inflammatory study

1) Mix

Add 2 mL BAC water. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Commonly used in loading/maintenance cycles for tissue-repair discussions.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low 1 mg 2× weekly × 4 weeks 20 U 10 doses/vial
Loading 2 mg 2× weekly × 4 weeks 40 U 5 doses/vial
High loading 4 mg Weekly × 4 weeks or split; clinician-only 80 U 2.5 doses/vial
Maintenance 2 mg Every 1–2 weeks 40 U 5 doses/vial

Note: 10 mg + 2 mL = 5 mg/mL. 1 mg = 20 U; 2 mg = 40 U.

Pure Peptides catalog lists TB-500 10 mg

1) Mix

Add 3 mL BAC water. This makes 33.33 mg/mL. On U-100: 10 U = 3.33 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Copper peptide associated with skin-repair and cosmetic-aging pathways; injectable evidence is mostly off-label.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Simple low5 U draw 1.67 mg Daily or 5× weekly 5 U 59.9 doses/vial
Simple higher10 U draw 3.33 mg Daily short course 10 U 30 doses/vial

Note: 100 mg is too concentrated for exact 1 mg draws in a 3 mL vial. Simple rule: 5 U ≈ 1.7 mg, 10 U ≈ 3.3 mg.

Pure Peptides catalog lists GHK-Cu 100 mg

1) Mix

Add 3 mL BAC water. This makes 23.33 mg/mL. On U-100: 10 U = 2.33 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Used as a component blend for skin appearance plus recovery support.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Easy low GHK 0.8 mg + BPC/TB 0.17 mg each Daily or 5× weekly 5 U 60 doses/vial
Common GHK 1.7 mg + BPC/TB 0.33 mg each Daily or 5× weekly 10 U 30 doses/vial
Higher GHK 2.5 mg + BPC/TB 0.5 mg each Daily short course 15 U 20 doses/vial

Note: Assumes 70 mg = GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg. Component blend amounts can vary by batch/formulation.

Pure Peptides product page: GLOW 70 mg

1) Mix

Add 3 mL BAC water. This makes 26.67 mg/mL. On U-100: 10 U = 2.67 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Adds KPV to a GLOW-style recovery/aesthetic blend for gut/skin inflammation discussions.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Easy low GHK 0.8 mg + others 0.17 mg each Daily or 5× weekly 5 U 60 doses/vial
Common GHK 1.7 mg + others 0.33 mg each Daily or 5× weekly 10 U 30 doses/vial
Higher GHK 2.5 mg + others 0.5 mg each Daily short course 15 U 20 doses/vial

Note: Assumes 80 mg = GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg.

Pure Peptides catalog/homepage

1) Mix

Add 3 mL sterile water/BAC per protocol. This makes 500 mg/mL. On U-100: 10 U = 50 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Master intracellular antioxidant involved in redox buffering and detox pathways.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Low injection 250 mg 1–3× weekly × 4 weeks 50 U 6 doses/vial
Common injection 500 mg 1–3× weekly × 4 weeks 100 U 3 doses/vial

Note: 1500 mg + 3 mL = 500 mg/mL. Higher 600–1200 mg injections exceed 100 U and are usually handled as clinic IM/IV volumes, not small insulin-syringe dosing.

General glutathione product/reference context

1) Mix

Add 2 mL 0.6% acetic acid stock. This makes 0.5 mg/mL. On U-100: 10 U = 0.05 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Potent growth-factor analog; requires careful screening due to glucose and proliferation-related concerns.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Easy low 0.025 mg Daily; 4–6 weeks 5 U 40 doses/vial
Common 0.05 mg Daily; 4–6 weeks 10 U 20 doses/vial

Note: Use acetic acid stock. 1 mg + 2 mL = 0.5 mg/mL, so 0.025 mg = 5 U and 0.05 mg = 10 U.

Pure Peptides homepage featured product IGF-1 LR3 1 mg

1) Mix

Add 2 mL BAC water if injected. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Commonly used before bed in small doses; evidence base is limited and older.

Route: SubQ or intranasal depending protocol

Dose level Dose Simple schedule Draw Vial count
Low sleep 0.25 mg 30–60 min before bed, PRN 5 U 40 doses/vial
Common sleep 0.5 mg 30–60 min before bed, PRN 10 U 20 doses/vial
High sleep 1 mg Clinician-only 20 U 10 doses/vial

Intranasal spray option

Easy nasal prep: 10 mg peptide + 10 mL sterile saline = 0.1 mg per puff assuming a 0.10 mL spray pump. Stronger prep: 10 mg + 5 mL sterile saline = 0.2 mg per puff.

Target 0.1 mg/puff prep 0.2 mg/puff prep
0.1 mg 1 puff —
0.2 mg 2 puffs 1 puff
0.3 mg 3 puffs —
0.5 mg 5 puffs 2–3 puffs

Use sterile 0.9% saline, not BAC water, for nasal spray. Pump output varies; prime and verify the bottle.

Note: Avoid combining with sedatives unless clinician reviewed. Intranasal is off-label/common online, not a validated approved route.

Pure Peptides catalog lists Delta Sleep Inducing Peptide 10 mg

1) Mix

Add 1 mL BAC water. This makes 10 mg/mL. On U-100: 10 U = 1 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Longevity-focused peptide with historical Eastern European clinical use; modern evidence is limited.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Common 5 mg Daily × 10–20 days 50 U 2 doses/vial
Higher common 10 mg Daily × 10 days 100 U 1 doses/vial

Note: Common cycles are 5–10 mg/day for 10–20 days, repeated only after long breaks if clinically appropriate.

Pure Peptides catalog lists Epithalon 10 mg and 50 mg

1) Mix

Add 2.5 mL BAC water. This makes 20 mg/mL. On U-100: 10 U = 2 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Longevity-focused peptide with historical Eastern European clinical use; modern evidence is limited.

Route: SubQ unless clinician specifies otherwise

Dose level Dose Simple schedule Draw Vial count
Common 5 mg Daily × 10–20 days 25 U 10 doses/vial
Higher common 10 mg Daily × 10 days 50 U 5 doses/vial

Note: Common cycles are 5–10 mg/day for 10–20 days, repeated only after long breaks if clinically appropriate.

Pure Peptides catalog lists Epithalon 10 mg and 50 mg

1) Mix

Add 2 mL BAC water if injected. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Commonly discussed for anxiety/stress regulation and calm focus.

Route: Intranasal preferred; SubQ only if protocol specifies

Dose level Dose Simple schedule Draw Vial count
Injectable low 0.25 mg Daily or 1–2× daily 5 U 40 doses/vial
Injectable common 0.5 mg Daily or 1–2× daily 10 U 20 doses/vial
Injectable high 1 mg Daily; clinician-only 20 U 10 doses/vial

Intranasal spray option

Easy nasal prep: 10 mg peptide + 10 mL sterile saline = 0.1 mg per puff assuming a 0.10 mL spray pump. Stronger prep: 10 mg + 5 mL sterile saline = 0.2 mg per puff.

Target 0.1 mg/puff prep 0.2 mg/puff prep
0.25 mg 2–3 puffs —
0.5 mg 5 puffs 2–3 puffs
1 mg 10 puffs 5 puffs

Use sterile 0.9% saline, not BAC water, for nasal spray. Pump output varies; prime and verify the bottle.

Note: Prefer the intranasal prep for Selank unless a clinician specifically wants injection.

Pure Peptides catalog lists Selank 10 mg

1) Mix

Add 2 mL BAC water if injected. This makes 5 mg/mL. On U-100: 10 U = 0.5 mg.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Most commonly used intranasally for focus and neurocognitive protocols.

Route: Intranasal preferred; SubQ only if protocol specifies

Dose level Dose Simple schedule Draw Vial count
Injectable low 0.25 mg Daily or 1–2× daily 5 U 40 doses/vial
Injectable common 0.5 mg Daily or 1–2× daily 10 U 20 doses/vial
Injectable high 1 mg Daily; clinician-only 20 U 10 doses/vial

Intranasal spray option

Easy nasal prep: 10 mg peptide + 10 mL sterile saline = 0.1 mg per puff assuming a 0.10 mL spray pump. Stronger prep: 10 mg + 5 mL sterile saline = 0.2 mg per puff.

Target 0.1 mg/puff prep 0.2 mg/puff prep
0.1 mg 1 puff —
0.2 mg 2 puffs 1 puff
0.3 mg 3 puffs —
0.5 mg 5 puffs 2–3 puffs

Use sterile 0.9% saline, not BAC water, for nasal spray. Pump output varies; prime and verify the bottle.

Note: Prefer the intranasal prep for Semax unless a clinician specifically wants injection.

Pure Peptides catalog lists Semax 10 mg

1) Mix

Supply item only. Usually used to make an acidic stock solution; not a standalone dose.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Useful when a peptide requires acidic stock conditions for stability before any working dilution.

Route: Diluent only

Note: Do not substitute for BAC water unless the peptide protocol specifically calls for acetic acid.

Pure Peptides search drawer shows Acetic Acid 3 mL

1) Mix

Supply item only. Use for injectable peptide reconstitution when BAC water is appropriate. Do not use for intranasal spray.

  • Inject water slowly down the glass wall.
  • Swirl/roll gently. Do not shake hard.
  • Label: date mixed + concentration.

2) What it is for

Preserved diluent for multi-dose vial use. Most Pure Peptides kits include a 3 mL BAC vial.

Route: Diluent only

Note: Check diluent compatibility. Some peptides, especially IGF-1 LR3 stock, use acetic acid instead.

Pure Peptides catalog lines show BAC Water 3 mL and 10 mL products

Reference use: Confirm vial size, route, diluent compatibility, storage, and patient-specific suitability before use. Duplicate single-vial/bulk listings are consolidated because the reconstitution math is identical.

Important: Injectable, intranasal, oral, IM, IV, and topical routes are not interchangeable. For professional guidance only.

Retatrutide

Avg Purity:

99.79%

Type Of Analysis:

HPLC-UV

Batch Number:

RETA-19467-21

 View Full Report

Tirzepatide

Avg Purity:

99.74%

Type Of Analysis:

HPLC-UV

Batch Number:

TIRZ-19467-6

 View Full Report

GHK-Cu

Avg Purity:

99.65%

Type Of Analysis:

HPLC-UV

Batch Number:

GHK-19447-7

 View Full Report

BPC-157

Avg Purity:

99.82%

Type Of Analysis:

HPLC-UV

Batch Number:

BPC-19467-13

 View Full Report

Mots-C

Avg Purity:

99.60%

Type Of Analysis:

HPLC-UV

Batch Number:

MOTS-19467-2

 View Full Report

Epithalon

Avg Purity:

99.33%

Type Of Analysis:

HPLC-UV

Batch Number:

EPI-19467-3

 View Full Report

Tesamorelin

Avg Purity:

99.17%

Type Of Analysis:

HPLC-UV

Batch Number:

TES-19467-18

 View Full Report

SS-31

Avg Purity:

99.75%

Type Of Analysis:

HPLC-UV

Batch Number:

SS31-19467-14

 View Full Report

TB-500

Avg Purity:

99.20%

Type Of Analysis:

HPLC-UV

Batch Number:

TB500-19467-16

 View Full Report

Selank

Avg Purity:

99.47%

Type Of Analysis:

HPLC-UV

Batch Number:

SEL-19467-7

 View Full Report

KPV

Avg Purity:

99.21%

Type Of Analysis:

HPLC-UV

Batch Number:

KPV-19467-1

 View Full Report

Semax

Avg Purity:

99.67%

Type Of Analysis:

HPLC-UV

Batch Number:

SMX-19697-5

 View Full Report

HGH (Somatropin)

Avg Purity:

99.43%

Type Of Analysis:

HPLC-UV

Batch Number:

HGH-19467-27

 View Full Report

Human Chorionic Gonadotropin (HCG)

Avg Purity:

99.75%

Type Of Analysis:

HPLC-UV

Batch Number:

HCG-19467-19

 View Full Report

IGF-1 LR3

Avg Purity:

99.32%

Type Of Analysis:

HPLC-UV

Batch Number:

EPI-19467-3

 View Full Report

CJC-1295 NO DAC/Ipamorelin

Avg Purity:

99.87%

Type Of Analysis:

HPLC-UV

Batch Number:

JS-CJCI-10-012926

 View Full Report

Glow Blend

Avg Purity:

n/a

Type Of Analysis:

HPLC-UV

Batch Number:

GLOW-19467-25

 View Full Report

Klow Blend

Avg Purity:

n/a

Type Of Analysis:

HPLC-UV

Batch Number:

KLOW-19467-26

 View Full Report